Top news
All coverage
Coronavirus: Covid News: U.S. Parents' Views Are Shifting on Vaccines (Published 2021)
By Benjamin Mueller, Shawn Hubler & Rebecca Robbins
Fauci sees hope in new Merck drug
By Quint Forgey
Merck could make up to $7 billion from its Covid-19 drugs in 2021
By Annalisa Merelli
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
By Manojna Maddipatla & Lewis Krauskopf
New antiviral drug prevents half of severe COVID-19 infections
By Karen Weintraub
Merck Pill Intended to Treat Covid-19 Succeeds in Key Study
By Betsy McKay & Jared S. Hopkins
How Merck's antiviral pill could change the game for COVID-19
By Meryl Davids Landau
Merck says experimental Covid pill cuts risk of death, hospitalization by 50 percent
By Erika Edwards
What would an antiviral pill mean for the fight against Covid-19?
By Virginia Langmaid